4//SEC Filing
Cavanaugh Sarah 4
Accession 0001415889-22-006731
CIK 0000744218other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:17 PM ET
Size
5.8 KB
Accession
0001415889-22-006731
Insider Transaction Report
Form 4
Cavanaugh Sarah
SVP OF CORP AFFAIRS & ADMIN.
Transactions
- Award
Incentive Stock Option (right to buy)
2022-06-16+73,000→ 73,000 totalExercise: $22.48From: 2023-06-16Exp: 2032-06-16→ Common Stock (73,000 underlying)
Footnotes (2)
- [F1]Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.
- [F2]25% vest on June 16, 2023 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.
Documents
Issuer
Celldex Therapeutics, Inc.
CIK 0000744218
Entity typeother
Related Parties
1- filerCIK 0001709113
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:17 PM ET
- Size
- 5.8 KB